AstraZeneca PLC ( AZNCF) - Key Metrics
AZNCF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q3 | $9.72 | $1.62 | $3.28 | $2.84 |
| 2025Q2 | $9.58 | $1.62 | $2.18 | $0.94 |
| 2025Q1 | $9.01 | $1.93 | $2.40 | $2.12 |
| 2024Q4 | $9.38 | $0.94 | $1.88 | $1.26 |
| 2024Q3 | $8.99 | $0.95 | $2.18 | $1.30 |
AZNCF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q3 | 63.60% | 23.20 |
| 2025Q2 | 0.40% | 21.41 |
| 2025Q1 | 111.73% | 18.80 |
| 2024Q4 | 0.20% | 34.66 |
| 2024Q3 | 107.13% | 40.93 |
AZNCF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q3 | 1.89% | 0.69% |
| 2025Q2 | 0.68% | 0.00% |
| 2025Q1 | 1.46% | 1.49% |
| 2024Q4 | 0.96% | 0.00% |
| 2024Q3 | 0.84% | 0.65% |
AZNCF
Price: $187.45
Dividend Yield: 1.56%
Forward Dividend Yield: 4.63%
Payout Ratio: 47.51%
Dividend Per Share: 8.68 USD
Earnings Per Share: 6.03 USD
P/E Ratio: 33.46
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United Kingdom
Market Capitalization: 312.8 billion
Average Dividend Frequency: 3
Years Paying Dividends: 18
DGR3: 30.00%
DGR5: 19.57%
DGR10: 9.73%